Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Medix - (AMEX: MXR) -- Ignore unavailable to you. Want to Upgrade?

To: REH who wrote (64)	12/8/1999 8:25:00 AM
From: micny	Respond to of 226

>>>"I think $ 0.50 is extremely cheap but the risks are still top range." Well, I have a sell order in at $.50. If you believe this why don't you take them? .............Still NO TAKERS! I guess others don't want as much for their shares as I want for mine.

To: REH who wrote (64)	12/8/1999 10:18:00 AM
From: Robert E. Winston	Read Replies (1) \| Respond to of 226

Another rave review that no one except us will see. Rolv, you seem to have connections at MDIX - do you know why the company passes up such golden opportunities to promote itself? Any other company would have rushed out a PR excerpting this report. And what about the government's plan to require insurers to cut back on errors? It seems an obvious opportunity for MDIX to point out that their pharmacy module can help do this. ragingbull.com ragingbull.com ragingbull.com ------------------ At 10:15 EST, not a single share has traded :-(